Enpatoran placebo, Enpatoran, Enpatoran
MS200569_0003
Phase 2 small_molecule active
Quick answer
Enpatoran placebo, Enpatoran, Enpatoran for Systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE) is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active